- Published on
Infectious Disease and Microbiology: Giardiasis
Giardiasis is a parasitic infection of the upper small intestine caused by Giardia lamblia (also known as Giardia intestinalis). It is one of the most common causes of protozoal diarrhea worldwide and is transmitted primarily via the fecal–oral route. Infection occurs through ingestion of cysts in contaminated water, food, or through direct person-to-person contact. Although many infections are asymptomatic, symptomatic cases can lead to prolonged gastrointestinal illness.
Epidemiologically, giardiasis has a global distribution and is especially common in areas with poor sanitation. It is responsible for thousands of cases annually, including approximately 20,000 cases per year in the United States. Outbreaks are often linked to contaminated water supplies, while sporadic cases commonly occur through direct transmission in settings such as daycare centers, institutions, and among individuals with close contact. Travelers to endemic regions, particularly in parts of Asia, are at increased risk.
The pathophysiology begins with ingestion of infective cysts, which are resistant and can survive in water for extended periods. Once ingested, the cysts undergo excystation in the upper gastrointestinal tract, releasing trophozoites that attach to the mucosa of the duodenum and jejunum. These organisms disrupt the intestinal brush border, leading to malabsorption and diarrhea. The infection does not typically invade tissues but causes functional impairment of absorption.
Clinically, giardiasis may be asymptomatic or present after an incubation period of about 1–3 weeks. The hallmark symptom is diarrhea, which is often subacute and may persist for weeks or months if untreated. Stools are typically pale, bulky, foul-smelling, and greasy due to fat malabsorption (steatorrhea). Other symptoms include abdominal cramps, bloating, excessive gas, weight loss, anorexia, and occasionally nausea or vomiting. Blood and mucus are usually absent, and systemic symptoms are mild. Chronic infection may occur, especially in immunocompromised individuals.
Diagnosis is primarily made by identifying cysts or trophozoites in stool samples through microscopy. Multiple stool examinations increase diagnostic yield. Antigen detection tests using ELISA or immunofluorescence are highly sensitive and specific and are commonly used. In rare or difficult cases, duodenal sampling may be required. Histological examination may show villous atrophy and mild inflammation.
Treatment is indicated for symptomatic patients and to prevent transmission in asymptomatic carriers, particularly children. First-line therapy includes Metronidazole, Tinidazole, or Nitazoxanide, all of which are highly effective. Alternative treatments include albendazole or quinacrine in resistant cases. Patients should avoid alcohol while taking metronidazole due to adverse reactions. Persistent or recurrent infection may require retreatment or evaluation of close contacts.
The prognosis of giardiasis is generally good, with most cases resolving either spontaneously or with treatment. However, untreated infection may lead to chronic diarrhea, malabsorption, steatorrhea, and weight loss. Complications can include lactose intolerance and nutritional deficiencies. Preventive measures such as proper sanitation, boiling or filtering drinking water, and good personal hygiene are essential in reducing transmission.
0 Comments
